Generic Industry Consolidating But Still Mysterious

Nearly 2,000 ANDAs remain unclaimed as US FDA begins fee calculations for GDUFA II.

FDA entrance sign 2016

The US FDA will calculate the newest generic drug user fee based on ANDA ownership with some 1,900 applications classified as unclaimed.

Applications with missing ownership data account for about 20% of all the ANDAs that FDA has approved, and the information...

More from Generics

More from Biosimilars & Generics